Friday, December 19, 2014 Last update: 7:03 AM - Covering Large & Obscure Tech Companies Since 1996

Biogen Idec in Panel at the Citi 9th Annual Biotech Conference

Companies mentioned in this article: Biogen Idec Inc.

CAMBRIDGE, Mass. -- (BUSINESS WIRE) -- Biogen Idec Inc. (NASDAQ: BIIB) announced today that it will participate in a panel at the Citi 9th Annual Biotech Conference. The webcast will be live on Thursday, September 4, 2014 at 10:00a.m. ET. To access the live webcast, please visit Biogen Idec’s Investors section at An archived version of the webcast will be available for 14 days following the presentation.

About Biogen Idec

Through cutting-edge science and medicine, Biogen Idec discovers, develops and delivers to patients worldwide innovative therapies for the treatment of neurodegenerative diseases, hemophilia and autoimmune disorders. Founded in 1978, Biogen Idec is the world’s oldest independent biotechnology company. Patients worldwide benefit from its leading multiple sclerosis therapies. For product labeling, press releases and additional information about the company, please visit

Copyright © Business Wire 2014

Biogen Idec
Karen Jewell, 781.464.2442
Investor Relations